Early versus Late Discontinuation of Maintenance Therapy in ... - MDPI
To determine if continuous low-dose chemotherapy after a transplant could improve overall survival and keep the disease controlled for longer periods. IFM_05-May 2022
Due to the risk of secondary cancers identified in the IFM-05 trial, long-term monitoring for new symptoms or blood changes is standard practice for those on this regimen. Early versus Late Discontinuation of Maintenance Therapy in
Patients are encouraged to discuss the balance between disease control and the toxic long-term effects of maintenance drugs with their oncology team. Patients are encouraged to discuss the balance between
The (often referred to simply as the IFM-05 study) focused on using lenalidomide as a maintenance treatment.
Lenalidomide was the primary drug used for maintenance in this study. Key Findings:
If you are looking for guidance based on this study's results: